Brind.

Company Reports $13.9M Net Product Revenue Amid $70.2M Net Loss

1 report, 1 independent Updated Nov 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The company reported Net Product Revenue of $13.9 million, which represents 53% sequential growth from the second quarter of 2026. Collaboration Revenue was $8.9 million, while the company recorded a Net Loss of $70.2 million. Cash and Equivalents stood at $492.1 million as of September 30, 2026.

From fool.com

Why it matters

Some supportBrind's analysis of the reports

The reported revenue growth in both net product and collaboration streams indicates strong operational activity and market demand for the company's offerings. Management expects current cash reserves to support the operating plan beyond the 2028 trial results.

From fool.com

Who's involved

  • Edward WilsonExecutive involved in the company reporting financial results
  • LeoniExecutive involved in the company reporting financial results
  • Kyowa KirinPharmaceutical company mentioned in the context of collaboration

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Jefferies Financial Group might adjust investment ratings and outlook based on the reported financial performance.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped